Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Can... por Sofie H. Tolmeijer (15313251)

Outros autores:

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Can... por Sofie H. Tolmeijer (15313251)

Outros autores:

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Can... por Sofie H. Tolmeijer (15313251)

Outros autores:

Figure 6 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Figure 4 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Figure 3 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Figure 7 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores:

Figure 1 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer por Martin Sjöström (14845882)

Outros autores: